APA

Ojo K. K., Gillespie J. R., Riechers A. J., Napuli A. J., Verlinde C. L. M. J., Buckner F. S., Gelb M. H., Domostoj M. M., Wells S. J., Scheer A., Wells T. N. C. & Van Voorhis W. C. (20090109). Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy. : Antimicrobial agents and chemotherapy.

Chicago

Ojo Kayode K, Gillespie J Robert, Riechers Aaron J, Napuli Alberto J, Verlinde Christophe L M J, Buckner Frederick S, Gelb Michael H, Domostoj Mathias M, Wells Susan J, Scheer Alexander, Wells Timothy N C and Van Voorhis Wesley C. 20090109. Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy. : Antimicrobial agents and chemotherapy.

Harvard

Ojo K. K., Gillespie J. R., Riechers A. J., Napuli A. J., Verlinde C. L. M. J., Buckner F. S., Gelb M. H., Domostoj M. M., Wells S. J., Scheer A., Wells T. N. C. and Van Voorhis W. C. (20090109). Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy. : Antimicrobial agents and chemotherapy.

MLA

Ojo Kayode K, Gillespie J Robert, Riechers Aaron J, Napuli Alberto J, Verlinde Christophe L M J, Buckner Frederick S, Gelb Michael H, Domostoj Mathias M, Wells Susan J, Scheer Alexander, Wells Timothy N C and Van Voorhis Wesley C. Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy. : Antimicrobial agents and chemotherapy. 20090109.